dapagliflozin

Italy

Drugs containing this active substance

  • DAPAGLIFLOZIN AUROBINDO

    This medicine is used to treat type 2 diabetes in adults and children aged 10 years and older. It is also used in adults (from 18 years of age) for heart failure and chronic kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

  • This medicine is used to treat type 2 diabetes (in adults and children aged 10 years and older), heart failure in adults, and chronic kidney disease in adults with reduced renal function.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: DOC GENERICI SRL

  • The drug is indicated for the treatment of type 2 diabetes mellitus in adults and children aged 10 years and older (either as monotherapy or in combination with other medicines), for the treatment of symptomatic chronic heart failure in adults, and for the treatment of chronic kidney disease in adults.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: TECNIGEN S.R.L.

  • This medicine is used to treat type 2 diabetes in adults and children aged 10 years and older (when not controlled by diet and exercise), heart failure in adults, and chronic kidney disease in adults with reduced kidney function.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: TEVA B.V.

  • It is used to treat type 2 diabetes in adults and children aged 10 years and older, heart failure in adults, and chronic kidney disease in adults with reduced kidney function.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: VIATRIS LIMITED

  • It is used for the treatment of type 2 diabetes in adults, when diabetes cannot be controlled with other medicines. It works by helping to remove excess sugar through the urine and by inhibiting glucose production in the liver.

    Form: tablets, film-coated

    Active substance Dosage
    metformin -
    dapagliflozin -

    ATC: A10BD15

    Manufacturer: ASTRAZENECA AB

  • It is used to treat type 2 diabetes in adults aged 10 years and older (when diet and exercise are not sufficient), heart failure in adults, and chronic kidney disease in adults with reduced renal function.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: ASTRAZENECA AB

  • This medicine is used to treat type 2 diabetes in adults and children aged 10 years and older, heart failure in adults, and chronic kidney disease in adults with reduced kidney function.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.

  • Qtern is used for the treatment of type 2 diabetes mellitus in adults, when blood glucose control is insufficient with the use of saxagliptin or dapagliflozin alone in combination with metformin and/or sulfonylurea.

    Form: tablets, film-coated

    Active substance Dosage
    saxagliptin -
    dapagliflozin -

    ATC: A10BD21

    Manufacturer: ASTRAZENECA AB

  • It is used for the treatment of type 2 diabetes in adults, when diabetes cannot be controlled with other medicines. It works by helping the body eliminate excess sugar through the urine and by reducing glucose production in the liver.

    Form: tablets, film-coated

    Active substance Dosage
    metformin -
    dapagliflozin -

    ATC: A10BD15

    Manufacturer: ASTRAZENECA AB

  • Zinodap is used to treat type 2 diabetes (in adults and children aged 10 years and older), heart failure in adults, and chronic kidney disease in adults with reduced renal function.

    Form: tablets, film-coated

    Active substance Dosage
    dapagliflozin -

    ATC: A10BK01

    Manufacturer: FARMITALIA INDUSTRIA CHIMICO FARMACEUTICA S.R.L.